CAR-T cell researchers optimistic about future of treating blood cancers
Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers.
Sep 15, 2023
0
40
Immune System Diseases: News and Research on Multiple Myeloma
MeSH tree: C20.683.780.650
Immunologist wins 'Breakthrough Prize' for innovative cancer treatment
When Michel Sadelain began his decades-long quest to genetically modify immune cells to fight cancer, his peers dismissed his ideas as absurd and even his mother grew concerned for his career.
Sep 14, 2023
0
79
Immune system plays vital role in longer multiple myeloma remission, new study shows
A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other top-tier cancer centers highlights the vital role that the immune system plays in determining ...
Sep 6, 2023
0
60
Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are part of an international team of scientists who identified mechanisms by which some multiple myelomas become resistant ...
Aug 31, 2023
0
45
Oral agent found to produce high response rate in patients with multiple myeloma when combined with steroid
A new agent that subverts myeloma cells from within while also subjecting them to an immune system attack produced impressive responses in combination with dexamethasone in patients with multiple myeloma that had relapsed ...
Aug 30, 2023
0
60
Dual acting drug delivers blood cancer a lethal 'one-two' punch in mice
Melbourne researchers have designed a single drug that delivers a lethal "one-two" punch to several types of blood cancer in preclinical studies and could lead to improved treatments.
Aug 30, 2023
0
48
FDA provides accelerated approval of Talvey for multiple myeloma
The U.S. Food and Drug Administration has approved Talvey (talquetamab-tvgs) for patients with relapsed or refractory multiple myeloma.
Aug 16, 2023
0
42
Younger patients with multiple myeloma can achieve durable survival
Younger adults with newly diagnosed multiple myeloma who receive an autologous stem cell transplant (auto-HCT) have a median progression-free survival (PFS) of approximately 3.5 years and a median overall survival (OS) of ...
Jul 27, 2023
0
48
New innovation in CAR T cells paves way for less toxic therapy against multiple myeloma
University of Maryland School of Medicine (UMSOM) researchers engineered a new type of CAR T-cell therapy that, in preclinical studies, selectively attacked cancer cells while sparing healthy cells, potentially reducing the ...
Jul 20, 2023
0
60
Multiple myeloma symptoms are generally nonspecific
Multiple myeloma (MM) symptoms are generally nonspecific, according to a study published online June 25 in Cancers.
Jul 19, 2023
0
36
